IRIS
CHIARANTINI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.690
EU - Europa 6.533
AS - Asia 2.502
OC - Oceania 19
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 11
Totale 17.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.653
GB - Regno Unito 2.622
CN - Cina 1.668
IT - Italia 1.121
UA - Ucraina 1.053
SE - Svezia 606
FI - Finlandia 398
TR - Turchia 384
DE - Germania 307
SG - Singapore 281
IE - Irlanda 213
FR - Francia 76
IN - India 52
KR - Corea 43
RU - Federazione Russa 42
CA - Canada 33
BE - Belgio 25
AU - Australia 17
VN - Vietnam 17
ES - Italia 14
IR - Iran 12
PL - Polonia 12
EU - Europa 10
NL - Olanda 9
TG - Togo 8
PK - Pakistan 7
AT - Austria 5
CH - Svizzera 5
HK - Hong Kong 5
BR - Brasile 4
DK - Danimarca 4
JP - Giappone 4
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
PA - Panama 3
SA - Arabia Saudita 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
EC - Ecuador 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
RS - Serbia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 17.781
Salva come PNG Salva come JPEG
Città #
Southend 2.440
Fairfield 1.049
Woodbridge 1.046
Jacksonville 860
Houston 846
Chandler 689
Ann Arbor 659
Ashburn 474
Cambridge 473
Nanjing 459
Seattle 440
Wilmington 396
Izmir 309
Urbino 229
Singapore 225
Boardman 214
Dublin 213
Nanchang 167
Helsinki 159
San Mateo 129
Princeton 125
New York 115
Beijing 103
Shenyang 97
Jiaxing 84
Hebei 82
Tianjin 77
Changsha 68
Düsseldorf 60
Mülheim 56
Jinan 55
Kunming 50
San Diego 49
Istanbul 45
Shanghai 44
Bremen 42
Milan 37
San Francisco 33
Guangzhou 32
Seongnam 30
Velikiy Novgorod 27
Brussels 24
London 24
Ningbo 23
Santa Clara 23
Zhengzhou 21
Toronto 20
Hangzhou 19
Ancona 17
Des Moines 17
Taizhou 17
Munich 16
Rome 16
Dong Ket 14
Lanzhou 13
Los Angeles 11
Auburn Hills 10
Bologna 10
Fuzhou 9
Haikou 9
Melbourne 9
Mergo 9
Norwalk 9
Turin 9
Frankfurt am Main 8
Kraków 8
Lomé 8
Osimo 8
Redwood City 8
West Jordan 8
Changchun 7
Falls Church 7
Leawood 7
Orange 7
Perugia 7
Portland 7
Avola 6
Gioia del Colle 6
Gunzenhausen 6
Ardabil 5
Augusta 5
Baranzate 5
Canberra 5
Fermo 5
Madrid 5
Mumbai 5
Paris 5
Ravenna 5
Shenzhen 5
Venice 5
Wuhan 5
Acton 4
Civitanova Marche 4
Hamilton 4
Hassan Abdal 4
Modena 4
Monmouth Junction 4
Naples 4
Pesaro 4
Pescara 4
Totale 13.340
Salva come PNG Salva come JPEG
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 455
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 345
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 227
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 225
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 210
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 206
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 206
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 205
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 205
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 203
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 202
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 201
Erythrocyte-based drug delivery 198
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 196
Drug delivery through phagocytosis of red blood cells 194
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 194
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 192
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 190
Inhibition of murine AIDS by reduced glutathione. 189
2',3'-Dideoxycytidine induced drug resistance in human cells 189
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 188
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 185
Comparison of novel delivery systems for antisense peptide nucleic acids 183
2',3'-Dideoxycytidine induced drug-resistance in human cells 175
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 173
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 173
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 172
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 170
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 166
Immunological quantification of human hexokinase type I 165
Red blood cells as a glucocorticoids delivery system 164
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 163
Human erythrocyte hexokinases are immunologically related 162
Red blood cells as glucocorticoids delivery system. 161
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 158
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 158
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 157
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 157
Development of a multilevel approach for the evaluation of nanomaterials toxicity 155
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 154
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 154
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 153
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 153
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 150
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 150
The interaction of phosphorylated sugars with human hexokinase I. 149
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 148
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 147
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 146
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 146
Targeting dexamethasone to macrophages. 145
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 145
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 142
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 141
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 141
Similarities and differences between human and rat hexokinases type I. 140
Red blood cell phagocytosis following hexokinase inactivation. 139
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 138
Immunological studies on mammalian hexokinase 138
CYTOTOXICITY OF NANOPARTICLES 138
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 138
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 137
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 137
Red blood cells as carriers of drugs against retroviruses 137
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 136
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 136
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 136
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 133
Red blood cells as an antigen-delivery system. 133
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 133
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 133
Esocinasi in fibroblasti umani. 132
Modulated red blood cell survival by membrane protein clustering 131
In vitro evaluation of nanomaterials toxicity 129
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 129
Vaccination strategy using red blood cells as antigen delivery system. 127
Introduction to in vivo targeting. 126
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 126
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 124
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 124
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 124
New drug combinations for the treatment of murine AIDS and macrophage protection. 124
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 123
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 122
Immobilization of enzymes and proteins on red blood cells. 118
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 118
Immobilization of enzymes and proteins on red blood cells. 115
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 113
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 112
Role of macrophage protection in the development of murine AIDS. 111
New synthesis of a spin-labelled peptide nucleic acids and its interactions with nucleic acids 110
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 108
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 108
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 106
Role of macrophage protection in the development of murine AIDS 103
Immunological studies on mammalian hexokinase. 102
Decay mechanisms of rabbit hexokinase during reticulocyte maturation 101
Quantification of electrophoretic eluted protein. 101
Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate. 99
Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 98
Totale 15.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.678 0 0 0 0 154 272 333 272 173 217 87 170
2020/20212.050 65 159 129 243 121 175 99 163 319 170 294 113
2021/20221.277 80 120 157 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024653 74 39 38 65 46 162 22 67 8 59 19 54
2024/2025903 102 109 496 157 39 0 0 0 0 0 0 0
Totale 17.920